Understanding more about RSV and the risk to older adults
- Respiratory syncytial virus (RSV) can cause serious complications in adults aged 60 years or older, particularly in those with chronic health conditions, such as heart disease and diabetes.
- Don’t let RSV come between you and your loved ones.
Risk
RSV can be serious
Most people who catch RSV recover within a week or two by resting at home. However, adults aged 60 years or older may have weakened immune systems, putting them at increased risk of severe complications, such as breathing difficulties, which can lead to hospital admission. In a small number of cases, RSV can be fatal.
Take this short questionnaire and speak to your healthcare professional about ways to help prevent RSV.
After discharge from hospital, some older adults may have trouble with daily activities, such as:4-6
- Getting dressed
- Going to the bathroom
- Feeding themselves
*Majority of study participants were aged >75 years; many had other chronic health issues and were admitted to hospital for conditions other than RSV.
RSV symptoms can range from mild to severe
RSV can start with mild symptoms similar to the common cold, such as congestion,
runny nose, sore throat or fever. But RSV may escalate to more severe symptoms.
- Wet cough A cough that produces phlegm or mucus.
- Wheezing A high-pitched whistling sound made while breathing.
- Gasping for breath Laboured or difficulty breathing, or shortness of breath.
- Pneumonia An infection that causes fluid in the lungs, making it difficult to breathe.
Managing RSV
If you get sick with RSV, your doctor may tell you to:
- Drink fluids and take over-the-counter medicines that help reduce fever and aches.
- Go to the hospital if your symptoms quickly become worse or you are having trouble breathing.
Babies are also at risk of getting sick due to RSV

References:
- Saravanos GL, et al. Med J Aust. 2019;210:447-445.
- Ackerson B, et al. Clin Infect Dis. 2019;69:197-203.
- Australian Bureau of Statistics. National Health Survey, 2022 (including data prepared for Pfizer).
- Branche AR, et al. Influenza Other Respir Viruses. 2022;16:1151-1160.
- Soh CH, et al. Med J Aust. 2021;215:173-179.
- Lowthian JA, et al. Age Ageing. 2017;46:219-225.